nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—Fluoxymesterone—breast cancer	0.301	1	CrCtD
Spironolactone—PGR—breast cancer	0.06	0.331	CbGaD
Spironolactone—SHBG—breast cancer	0.056	0.309	CbGaD
Spironolactone—AR—breast cancer	0.0491	0.271	CbGaD
Spironolactone—SHBG—Fluoxymesterone—breast cancer	0.0431	0.221	CbGbCtD
Spironolactone—AR—Fluoxymesterone—breast cancer	0.036	0.185	CbGbCtD
Spironolactone—NR3C1—Fluoxymesterone—breast cancer	0.0229	0.118	CbGbCtD
Spironolactone—Dydrogesterone—Exemestane—breast cancer	0.0212	0.0992	CrCrCtD
Spironolactone—Eplerenone—Fluoxymesterone—breast cancer	0.0185	0.0866	CrCrCtD
Spironolactone—Oxandrolone—Fluoxymesterone—breast cancer	0.0174	0.0812	CrCrCtD
Spironolactone—SLCO1A2—Chlorambucil—breast cancer	0.0164	0.0841	CbGbCtD
Spironolactone—ABCB1—breast cancer	0.0161	0.0888	CbGaD
Spironolactone—Dydrogesterone—Fluoxymesterone—breast cancer	0.0147	0.0688	CrCrCtD
Spironolactone—Potassium Canrenoate—Fluoxymesterone—breast cancer	0.014	0.0655	CrCrCtD
Spironolactone—Testolactone—Exemestane—breast cancer	0.014	0.0653	CrCrCtD
Spironolactone—Megestrol acetate—Fluoxymesterone—breast cancer	0.0128	0.0599	CrCrCtD
Spironolactone—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.0114	0.0533	CrCrCtD
Spironolactone—Testosterone—Exemestane—breast cancer	0.0109	0.0507	CrCrCtD
Spironolactone—Hydrocortamate—Fluoxymesterone—breast cancer	0.0103	0.0481	CrCrCtD
Spironolactone—Cortisone acetate—Fluoxymesterone—breast cancer	0.00998	0.0466	CrCrCtD
Spironolactone—Testolactone—Fluoxymesterone—breast cancer	0.00969	0.0453	CrCrCtD
Spironolactone—Fludrocortisone—Fluoxymesterone—breast cancer	0.00867	0.0405	CrCrCtD
Spironolactone—Progesterone—Fluoxymesterone—breast cancer	0.00867	0.0405	CrCrCtD
Spironolactone—Testosterone Propionate—Fluoxymesterone—breast cancer	0.00867	0.0405	CrCrCtD
Spironolactone—Methyltestosterone—Fluoxymesterone—breast cancer	0.00846	0.0395	CrCrCtD
Spironolactone—Testosterone—Fluoxymesterone—breast cancer	0.00753	0.0352	CrCrCtD
Spironolactone—Hydrocortisone—Fluoxymesterone—breast cancer	0.00707	0.033	CrCrCtD
Spironolactone—ABCC2—Tamoxifen—breast cancer	0.00598	0.0307	CbGbCtD
Spironolactone—CYP2C8—Lapatinib—breast cancer	0.00575	0.0295	CbGbCtD
Spironolactone—ABCB1—Toremifene—breast cancer	0.00534	0.0274	CbGbCtD
Spironolactone—ABCC2—Paclitaxel—breast cancer	0.00466	0.0239	CbGbCtD
Spironolactone—ABCC2—Irinotecan—breast cancer	0.00459	0.0236	CbGbCtD
Spironolactone—ABCC2—Carboplatin—breast cancer	0.00438	0.0225	CbGbCtD
Spironolactone—CYP2C8—Raloxifene—breast cancer	0.00436	0.0224	CbGbCtD
Spironolactone—ABCC2—Vinblastine—breast cancer	0.00408	0.021	CbGbCtD
Spironolactone—ABCB1—Lapatinib—breast cancer	0.00389	0.02	CbGbCtD
Spironolactone—ABCC2—Docetaxel—breast cancer	0.00337	0.0173	CbGbCtD
Spironolactone—SLCO1A2—Methotrexate—breast cancer	0.00293	0.0151	CbGbCtD
Spironolactone—CYP2C8—Tamoxifen—breast cancer	0.00288	0.0148	CbGbCtD
Spironolactone—PGR—corpus luteum—breast cancer	0.00284	0.166	CbGeAlD
Spironolactone—ABCC2—Doxorubicin—breast cancer	0.00251	0.0129	CbGbCtD
Spironolactone—ABCC2—Methotrexate—breast cancer	0.00243	0.0125	CbGbCtD
Spironolactone—CYP2C8—Paclitaxel—breast cancer	0.00224	0.0115	CbGbCtD
Spironolactone—ABCB1—Vinorelbine—breast cancer	0.00216	0.0111	CbGbCtD
Spironolactone—CYP2C8—Fluorouracil—breast cancer	0.00212	0.0109	CbGbCtD
Spironolactone—ABCB1—Tamoxifen—breast cancer	0.00195	0.01	CbGbCtD
Spironolactone—ABCB1—Mitoxantrone—breast cancer	0.0019	0.00977	CbGbCtD
Spironolactone—ABCB1—Gemcitabine—breast cancer	0.00168	0.00863	CbGbCtD
Spironolactone—ABCB1—Paclitaxel—breast cancer	0.00152	0.00779	CbGbCtD
Spironolactone—ABCB1—Irinotecan—breast cancer	0.0015	0.00769	CbGbCtD
Spironolactone—ABCB1—Vinblastine—breast cancer	0.00133	0.00684	CbGbCtD
Spironolactone—ABCB1—Docetaxel—breast cancer	0.0011	0.00564	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—breast cancer	0.000818	0.0042	CbGbCtD
Spironolactone—ABCB1—Methotrexate—breast cancer	0.000792	0.00407	CbGbCtD
Spironolactone—PGR—mammary gland—breast cancer	0.000441	0.0257	CbGeAlD
Spironolactone—CYP11B1—adrenal gland—breast cancer	0.000434	0.0253	CbGeAlD
Spironolactone—CYP11B2—adrenal gland—breast cancer	0.000434	0.0253	CbGeAlD
Spironolactone—NR3C2—nipple—breast cancer	0.000392	0.0228	CbGeAlD
Spironolactone—CYP11B2—endocrine gland—breast cancer	0.000376	0.0219	CbGeAlD
Spironolactone—CYP11B1—endocrine gland—breast cancer	0.000376	0.0219	CbGeAlD
Spironolactone—PGR—nipple—breast cancer	0.000365	0.0212	CbGeAlD
Spironolactone—AR—nipple—breast cancer	0.00029	0.0169	CbGeAlD
Spironolactone—CYP2C8—mammary gland—breast cancer	0.000284	0.0165	CbGeAlD
Spironolactone—Fluoxymesterone—PRLR—breast cancer	0.000277	0.145	CrCbGaD
Spironolactone—CYP11B2—lymph node—breast cancer	0.00026	0.0151	CbGeAlD
Spironolactone—PGR—epithelium—breast cancer	0.000245	0.0143	CbGeAlD
Spironolactone—SHBG—endometrium—breast cancer	0.000244	0.0142	CbGeAlD
Spironolactone—NR3C2—endometrium—breast cancer	0.000237	0.0138	CbGeAlD
Spironolactone—SHBG—uterus—breast cancer	0.000225	0.0131	CbGeAlD
Spironolactone—SHBG—pituitary gland—breast cancer	0.000221	0.0129	CbGeAlD
Spironolactone—SHBG—adipose tissue—breast cancer	0.00022	0.0128	CbGeAlD
Spironolactone—PGR—endometrium—breast cancer	0.00022	0.0128	CbGeAlD
Spironolactone—NR3C2—uterus—breast cancer	0.000218	0.0127	CbGeAlD
Spironolactone—NR3C2—pituitary gland—breast cancer	0.000214	0.0125	CbGeAlD
Spironolactone—NR3C2—adipose tissue—breast cancer	0.000213	0.0124	CbGeAlD
Spironolactone—NR3C1—nipple—breast cancer	0.00021	0.0123	CbGeAlD
Spironolactone—PGR—uterus—breast cancer	0.000203	0.0118	CbGeAlD
Spironolactone—SHBG—female reproductive system—breast cancer	0.000202	0.0118	CbGeAlD
Spironolactone—PGR—pituitary gland—breast cancer	0.000199	0.0116	CbGeAlD
Spironolactone—PGR—adipose tissue—breast cancer	0.000198	0.0116	CbGeAlD
Spironolactone—SHBG—adrenal gland—breast cancer	0.000198	0.0115	CbGeAlD
Spironolactone—NR3C2—female reproductive system—breast cancer	0.000196	0.0114	CbGeAlD
Spironolactone—AR—epithelium—breast cancer	0.000196	0.0114	CbGeAlD
Spironolactone—NR3C2—adrenal gland—breast cancer	0.000191	0.0111	CbGeAlD
Spironolactone—SHBG—bone marrow—breast cancer	0.000191	0.0111	CbGeAlD
Spironolactone—AR—skin of body—breast cancer	0.000186	0.0108	CbGeAlD
Spironolactone—SHBG—female gonad—breast cancer	0.000184	0.0107	CbGeAlD
Spironolactone—PGR—female reproductive system—breast cancer	0.000182	0.0106	CbGeAlD
Spironolactone—NR3C2—female gonad—breast cancer	0.000178	0.0104	CbGeAlD
Spironolactone—PGR—adrenal gland—breast cancer	0.000178	0.0104	CbGeAlD
Spironolactone—AR—endometrium—breast cancer	0.000175	0.0102	CbGeAlD
Spironolactone—NR3C1—embryo—breast cancer	0.000174	0.0101	CbGeAlD
Spironolactone—SHBG—endocrine gland—breast cancer	0.000171	0.00998	CbGeAlD
Spironolactone—NR3C2—endocrine gland—breast cancer	0.000166	0.00967	CbGeAlD
Spironolactone—PGR—female gonad—breast cancer	0.000166	0.00966	CbGeAlD
Spironolactone—AR—uterus—breast cancer	0.000162	0.00941	CbGeAlD
Spironolactone—AR—pituitary gland—breast cancer	0.000159	0.00924	CbGeAlD
Spironolactone—AR—adipose tissue—breast cancer	0.000158	0.00921	CbGeAlD
Spironolactone—ABCC2—female reproductive system—breast cancer	0.000157	0.00912	CbGeAlD
Spironolactone—PGR—endocrine gland—breast cancer	0.000154	0.00899	CbGeAlD
Spironolactone—ABCC2—adrenal gland—breast cancer	0.000153	0.0089	CbGeAlD
Spironolactone—AR—female reproductive system—breast cancer	0.000145	0.00846	CbGeAlD
Spironolactone—SLCO1A2—endocrine gland—breast cancer	0.000142	0.00829	CbGeAlD
Spironolactone—CYP2C8—endometrium—breast cancer	0.000142	0.00826	CbGeAlD
Spironolactone—AR—adrenal gland—breast cancer	0.000142	0.00826	CbGeAlD
Spironolactone—NR3C1—epithelium—breast cancer	0.000142	0.00825	CbGeAlD
Spironolactone—NR3C1—skin of body—breast cancer	0.000135	0.00785	CbGeAlD
Spironolactone—ABCC2—endocrine gland—breast cancer	0.000133	0.00772	CbGeAlD
Spironolactone—AR—female gonad—breast cancer	0.000132	0.0077	CbGeAlD
Spironolactone—CYP2C8—pituitary gland—breast cancer	0.000128	0.00748	CbGeAlD
Spironolactone—NR3C1—endometrium—breast cancer	0.000127	0.0074	CbGeAlD
Spironolactone—AR—endocrine gland—breast cancer	0.000123	0.00716	CbGeAlD
Spironolactone—Dydrogesterone—PGR—breast cancer	0.00012	0.0626	CrCbGaD
Spironolactone—CYP2C8—female reproductive system—breast cancer	0.000117	0.00684	CbGeAlD
Spironolactone—NR3C1—uterus—breast cancer	0.000117	0.00682	CbGeAlD
Spironolactone—NR3C1—pituitary gland—breast cancer	0.000115	0.00669	CbGeAlD
Spironolactone—NR3C2—lymph node—breast cancer	0.000115	0.00668	CbGeAlD
Spironolactone—NR3C1—adipose tissue—breast cancer	0.000114	0.00667	CbGeAlD
Spironolactone—Oxandrolone—AR—breast cancer	0.000107	0.0557	CrCbGaD
Spironolactone—PGR—lymph node—breast cancer	0.000107	0.00621	CbGeAlD
Spironolactone—NR3C1—female reproductive system—breast cancer	0.000105	0.00613	CbGeAlD
Spironolactone—NR3C1—adrenal gland—breast cancer	0.000103	0.00598	CbGeAlD
Spironolactone—CYP2C8—endocrine gland—breast cancer	9.94e-05	0.00579	CbGeAlD
Spironolactone—NR3C1—bone marrow—breast cancer	9.93e-05	0.00579	CbGeAlD
Spironolactone—NR3C1—female gonad—breast cancer	9.57e-05	0.00558	CbGeAlD
Spironolactone—ABCB1—embryo—breast cancer	9.29e-05	0.00541	CbGeAlD
Spironolactone—ABCC2—lymph node—breast cancer	9.16e-05	0.00534	CbGeAlD
Spironolactone—NR3C1—endocrine gland—breast cancer	8.9e-05	0.00519	CbGeAlD
Spironolactone—AR—lymph node—breast cancer	8.5e-05	0.00495	CbGeAlD
Spironolactone—ABCB1—epithelium—breast cancer	7.58e-05	0.00442	CbGeAlD
Spironolactone—Megestrol acetate—PGR—breast cancer	7.21e-05	0.0377	CrCbGaD
Spironolactone—Testosterone Propionate—CYP17A1—breast cancer	7.13e-05	0.0372	CrCbGaD
Spironolactone—ABCB1—endometrium—breast cancer	6.8e-05	0.00396	CbGeAlD
Spironolactone—Testolactone—CYP19A1—breast cancer	6.67e-05	0.0348	CrCbGaD
Spironolactone—Drospirenone—PGR—breast cancer	6.3e-05	0.0329	CrCbGaD
Spironolactone—ABCB1—uterus—breast cancer	6.27e-05	0.00365	CbGeAlD
Spironolactone—NR3C1—lymph node—breast cancer	6.15e-05	0.00359	CbGeAlD
Spironolactone—ABCB1—pituitary gland—breast cancer	6.15e-05	0.00358	CbGeAlD
Spironolactone—ABCB1—adipose tissue—breast cancer	6.13e-05	0.00357	CbGeAlD
Spironolactone—Testosterone Propionate—COMT—breast cancer	5.81e-05	0.0303	CrCbGaD
Spironolactone—ABCB1—female reproductive system—breast cancer	5.63e-05	0.00328	CbGeAlD
Spironolactone—ABCB1—adrenal gland—breast cancer	5.5e-05	0.0032	CbGeAlD
Spironolactone—ABCB1—bone marrow—breast cancer	5.32e-05	0.0031	CbGeAlD
Spironolactone—Drospirenone—AR—breast cancer	5.16e-05	0.027	CrCbGaD
Spironolactone—ABCB1—female gonad—breast cancer	5.13e-05	0.00299	CbGeAlD
Spironolactone—Fludrocortisone—AR—breast cancer	4.86e-05	0.0254	CrCbGaD
Spironolactone—ABCB1—endocrine gland—breast cancer	4.77e-05	0.00278	CbGeAlD
Spironolactone—Fluoxymesterone—SHBG—breast cancer	4.58e-05	0.0239	CrCbGaD
Spironolactone—Testosterone Propionate—AR—breast cancer	4.33e-05	0.0226	CrCbGaD
Spironolactone—Drospirenone—BCHE—breast cancer	4.31e-05	0.0225	CrCbGaD
Spironolactone—Medroxyprogesterone Acetate—PGR—breast cancer	4.2e-05	0.0219	CrCbGaD
Spironolactone—Renal failure acute—Doxorubicin—breast cancer	4.15e-05	0.000916	CcSEcCtD
Spironolactone—Diarrhoea—Melphalan—breast cancer	4.14e-05	0.000915	CcSEcCtD
Spironolactone—Nausea—Chlorambucil—breast cancer	4.13e-05	0.000911	CcSEcCtD
Spironolactone—Thrombocytopenia—Fluorouracil—breast cancer	4.09e-05	0.000903	CcSEcCtD
Spironolactone—Dizziness—Tamoxifen—breast cancer	4.09e-05	0.000903	CcSEcCtD
Spironolactone—Vomiting—Vinblastine—breast cancer	4.05e-05	0.000893	CcSEcCtD
Spironolactone—Ill-defined disorder—Paclitaxel—breast cancer	4.04e-05	0.000893	CcSEcCtD
Spironolactone—Diarrhoea—Goserelin—breast cancer	4.04e-05	0.000892	CcSEcCtD
Spironolactone—Fluoxymesterone—AR—breast cancer	4.01e-05	0.021	CrCbGaD
Spironolactone—Erythema multiforme—Docetaxel—breast cancer	4.01e-05	0.000886	CcSEcCtD
Spironolactone—Urticaria—Thiotepa—breast cancer	4.01e-05	0.000886	CcSEcCtD
Spironolactone—Body temperature increased—Thiotepa—breast cancer	3.99e-05	0.000882	CcSEcCtD
Spironolactone—Headache—Vinblastine—breast cancer	3.99e-05	0.00088	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Methotrexate—breast cancer	3.98e-05	0.000879	CcSEcCtD
Spironolactone—Vomiting—Tamoxifen—breast cancer	3.93e-05	0.000868	CcSEcCtD
Spironolactone—Malaise—Paclitaxel—breast cancer	3.93e-05	0.000868	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—SHBG—breast cancer	3.93e-05	0.0205	CrCbGaD
Spironolactone—Lethargy—Doxorubicin—breast cancer	3.91e-05	0.000863	CcSEcCtD
Spironolactone—Dizziness—Goserelin—breast cancer	3.91e-05	0.000862	CcSEcCtD
Spironolactone—Leukopenia—Paclitaxel—breast cancer	3.9e-05	0.000861	CcSEcCtD
Spironolactone—Rash—Tamoxifen—breast cancer	3.9e-05	0.000861	CcSEcCtD
Spironolactone—Hypersensitivity—Vinorelbine—breast cancer	3.9e-05	0.00086	CcSEcCtD
Spironolactone—Dermatitis—Tamoxifen—breast cancer	3.9e-05	0.00086	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—breast cancer	3.89e-05	0.000859	CcSEcCtD
Spironolactone—Erythema multiforme—Capecitabine—breast cancer	3.89e-05	0.000858	CcSEcCtD
Spironolactone—Somnolence—Mitoxantrone—breast cancer	3.88e-05	0.000856	CcSEcCtD
Spironolactone—Somnolence—Irinotecan—breast cancer	3.88e-05	0.000856	CcSEcCtD
Spironolactone—Headache—Tamoxifen—breast cancer	3.87e-05	0.000855	CcSEcCtD
Spironolactone—Vomiting—Melphalan—breast cancer	3.85e-05	0.00085	CcSEcCtD
Spironolactone—Rash—Melphalan—breast cancer	3.82e-05	0.000843	CcSEcCtD
Spironolactone—Dermatitis—Melphalan—breast cancer	3.81e-05	0.000842	CcSEcCtD
Spironolactone—Eosinophilia—Methotrexate—breast cancer	3.78e-05	0.000835	CcSEcCtD
Spironolactone—Nausea—Vinblastine—breast cancer	3.78e-05	0.000835	CcSEcCtD
Spironolactone—Somnolence—Gemcitabine—breast cancer	3.78e-05	0.000834	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Irinotecan—breast cancer	3.77e-05	0.000831	CcSEcCtD
Spironolactone—Vomiting—Goserelin—breast cancer	3.76e-05	0.000829	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—breast cancer	3.75e-05	0.000828	CcSEcCtD
Spironolactone—Pruritus—Vinorelbine—breast cancer	3.74e-05	0.000826	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—breast cancer	3.73e-05	0.000823	CcSEcCtD
Spironolactone—Rash—Goserelin—breast cancer	3.72e-05	0.000822	CcSEcCtD
Spironolactone—Hypersensitivity—Thiotepa—breast cancer	3.72e-05	0.000822	CcSEcCtD
Spironolactone—Dermatitis—Goserelin—breast cancer	3.72e-05	0.000821	CcSEcCtD
Spironolactone—Somnolence—Fluorouracil—breast cancer	3.71e-05	0.00082	CcSEcCtD
Spironolactone—Headache—Goserelin—breast cancer	3.7e-05	0.000817	CcSEcCtD
Spironolactone—Methyltestosterone—SHBG—breast cancer	3.7e-05	0.0193	CrCbGaD
Spironolactone—Nausea—Tamoxifen—breast cancer	3.67e-05	0.000811	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Gemcitabine—breast cancer	3.67e-05	0.00081	CcSEcCtD
Spironolactone—Discomfort—Paclitaxel—breast cancer	3.67e-05	0.000809	CcSEcCtD
Spironolactone—Gastritis—Epirubicin—breast cancer	3.66e-05	0.000809	CcSEcCtD
Spironolactone—Alopecia—Capecitabine—breast cancer	3.63e-05	0.000802	CcSEcCtD
Spironolactone—Diarrhoea—Vinorelbine—breast cancer	3.62e-05	0.000799	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Fluorouracil—breast cancer	3.61e-05	0.000796	CcSEcCtD
Spironolactone—Ataxia—Doxorubicin—breast cancer	3.6e-05	0.000795	CcSEcCtD
Spironolactone—Nausea—Melphalan—breast cancer	3.6e-05	0.000794	CcSEcCtD
Spironolactone—Feeling abnormal—Mitoxantrone—breast cancer	3.59e-05	0.000794	CcSEcCtD
Spironolactone—Feeling abnormal—Irinotecan—breast cancer	3.59e-05	0.000794	CcSEcCtD
Spironolactone—Confusional state—Paclitaxel—breast cancer	3.59e-05	0.000792	CcSEcCtD
Spironolactone—Pruritus—Thiotepa—breast cancer	3.57e-05	0.000789	CcSEcCtD
Spironolactone—Anaphylactic shock—Paclitaxel—breast cancer	3.56e-05	0.000785	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—breast cancer	3.55e-05	0.000784	CcSEcCtD
Spironolactone—Eosinophilia—Epirubicin—breast cancer	3.54e-05	0.000782	CcSEcCtD
Spironolactone—Erectile dysfunction—Methotrexate—breast cancer	3.52e-05	0.000777	CcSEcCtD
Spironolactone—Nausea—Goserelin—breast cancer	3.51e-05	0.000774	CcSEcCtD
Spironolactone—Feeling abnormal—Gemcitabine—breast cancer	3.5e-05	0.000773	CcSEcCtD
Spironolactone—Dizziness—Vinorelbine—breast cancer	3.5e-05	0.000772	CcSEcCtD
Spironolactone—Thrombocytopenia—Paclitaxel—breast cancer	3.48e-05	0.000769	CcSEcCtD
Spironolactone—Urticaria—Mitoxantrone—breast cancer	3.47e-05	0.000765	CcSEcCtD
Spironolactone—Diarrhoea—Thiotepa—breast cancer	3.46e-05	0.000763	CcSEcCtD
Spironolactone—Body temperature increased—Irinotecan—breast cancer	3.45e-05	0.000761	CcSEcCtD
Spironolactone—Body temperature increased—Mitoxantrone—breast cancer	3.45e-05	0.000761	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—breast cancer	3.45e-05	0.000761	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—AR—breast cancer	3.44e-05	0.018	CrCbGaD
Spironolactone—Feeling abnormal—Fluorouracil—breast cancer	3.44e-05	0.00076	CcSEcCtD
Spironolactone—Muscle spasms—Capecitabine—breast cancer	3.44e-05	0.000759	CcSEcCtD
Spironolactone—Drowsiness—Methotrexate—breast cancer	3.41e-05	0.000752	CcSEcCtD
Spironolactone—Gastritis—Doxorubicin—breast cancer	3.39e-05	0.000748	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Methotrexate—breast cancer	3.38e-05	0.000746	CcSEcCtD
Spironolactone—Vomiting—Vinorelbine—breast cancer	3.36e-05	0.000742	CcSEcCtD
Spironolactone—Body temperature increased—Gemcitabine—breast cancer	3.36e-05	0.000742	CcSEcCtD
Spironolactone—Renal failure—Methotrexate—breast cancer	3.35e-05	0.00074	CcSEcCtD
Spironolactone—Dizziness—Thiotepa—breast cancer	3.34e-05	0.000737	CcSEcCtD
Spironolactone—Rash—Vinorelbine—breast cancer	3.34e-05	0.000736	CcSEcCtD
Spironolactone—Dermatitis—Vinorelbine—breast cancer	3.33e-05	0.000736	CcSEcCtD
Spironolactone—Ill-defined disorder—Capecitabine—breast cancer	3.32e-05	0.000733	CcSEcCtD
Spironolactone—Urticaria—Fluorouracil—breast cancer	3.32e-05	0.000733	CcSEcCtD
Spironolactone—Headache—Vinorelbine—breast cancer	3.31e-05	0.000732	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—breast cancer	3.31e-05	0.00073	CcSEcCtD
Spironolactone—Body temperature increased—Fluorouracil—breast cancer	3.3e-05	0.000729	CcSEcCtD
Spironolactone—ABCB1—lymph node—breast cancer	3.29e-05	0.00192	CbGeAlD
Spironolactone—Eosinophilia—Doxorubicin—breast cancer	3.28e-05	0.000723	CcSEcCtD
Spironolactone—Progesterone—CYP17A1—breast cancer	3.27e-05	0.0171	CrCbGaD
Spironolactone—Methyltestosterone—AR—breast cancer	3.24e-05	0.0169	CrCbGaD
Spironolactone—Malaise—Capecitabine—breast cancer	3.23e-05	0.000712	CcSEcCtD
Spironolactone—Hypersensitivity—Irinotecan—breast cancer	3.21e-05	0.00071	CcSEcCtD
Spironolactone—Hypersensitivity—Mitoxantrone—breast cancer	3.21e-05	0.00071	CcSEcCtD
Spironolactone—Vomiting—Thiotepa—breast cancer	3.21e-05	0.000709	CcSEcCtD
Spironolactone—Leukopenia—Capecitabine—breast cancer	3.2e-05	0.000707	CcSEcCtD
Spironolactone—Drowsiness—Epirubicin—breast cancer	3.19e-05	0.000704	CcSEcCtD
Spironolactone—Rash—Thiotepa—breast cancer	3.19e-05	0.000703	CcSEcCtD
Spironolactone—Dermatitis—Thiotepa—breast cancer	3.18e-05	0.000702	CcSEcCtD
Spironolactone—Agranulocytosis—Methotrexate—breast cancer	3.18e-05	0.000702	CcSEcCtD
Spironolactone—Headache—Thiotepa—breast cancer	3.16e-05	0.000699	CcSEcCtD
Spironolactone—Somnolence—Paclitaxel—breast cancer	3.16e-05	0.000698	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—breast cancer	3.16e-05	0.000698	CcSEcCtD
Spironolactone—Nausea—Vinorelbine—breast cancer	3.14e-05	0.000694	CcSEcCtD
Spironolactone—Renal failure—Epirubicin—breast cancer	3.14e-05	0.000692	CcSEcCtD
Spironolactone—Fluoxymesterone—ESR1—breast cancer	3.09e-05	0.0161	CrCbGaD
Spironolactone—Hypersensitivity—Fluorouracil—breast cancer	3.08e-05	0.00068	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Paclitaxel—breast cancer	3.07e-05	0.000678	CcSEcCtD
Spironolactone—Confusional state—Docetaxel—breast cancer	3.04e-05	0.000671	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—breast cancer	3.02e-05	0.000666	CcSEcCtD
Spironolactone—Discomfort—Capecitabine—breast cancer	3.01e-05	0.000664	CcSEcCtD
Spironolactone—Pruritus—Gemcitabine—breast cancer	3.01e-05	0.000664	CcSEcCtD
Spironolactone—Nausea—Thiotepa—breast cancer	3e-05	0.000662	CcSEcCtD
Spironolactone—Diarrhoea—Irinotecan—breast cancer	2.98e-05	0.000659	CcSEcCtD
Spironolactone—Diarrhoea—Mitoxantrone—breast cancer	2.98e-05	0.000659	CcSEcCtD
Spironolactone—Agranulocytosis—Epirubicin—breast cancer	2.98e-05	0.000657	CcSEcCtD
Spironolactone—Progesterone—ABCC1—breast cancer	2.97e-05	0.0155	CrCbGaD
Spironolactone—Pruritus—Fluorouracil—breast cancer	2.96e-05	0.000653	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—breast cancer	2.95e-05	0.000652	CcSEcCtD
Spironolactone—Drowsiness—Doxorubicin—breast cancer	2.95e-05	0.000651	CcSEcCtD
Spironolactone—Confusional state—Capecitabine—breast cancer	2.94e-05	0.00065	CcSEcCtD
Spironolactone—Feeling abnormal—Paclitaxel—breast cancer	2.93e-05	0.000647	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—breast cancer	2.93e-05	0.000646	CcSEcCtD
Spironolactone—Diarrhoea—Gemcitabine—breast cancer	2.91e-05	0.000642	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—breast cancer	2.9e-05	0.00064	CcSEcCtD
Spironolactone—Erythema multiforme—Methotrexate—breast cancer	2.89e-05	0.000639	CcSEcCtD
Spironolactone—Dizziness—Irinotecan—breast cancer	2.88e-05	0.000637	CcSEcCtD
Spironolactone—Diarrhoea—Fluorouracil—breast cancer	2.86e-05	0.000631	CcSEcCtD
Spironolactone—Thrombocytopenia—Capecitabine—breast cancer	2.86e-05	0.000631	CcSEcCtD
Spironolactone—Urticaria—Paclitaxel—breast cancer	2.83e-05	0.000624	CcSEcCtD
Spironolactone—Body temperature increased—Paclitaxel—breast cancer	2.81e-05	0.000621	CcSEcCtD
Spironolactone—Hydrocortisone—SHBG—breast cancer	2.78e-05	0.0145	CrCbGaD
Spironolactone—Vomiting—Mitoxantrone—breast cancer	2.77e-05	0.000612	CcSEcCtD
Spironolactone—Vomiting—Irinotecan—breast cancer	2.77e-05	0.000612	CcSEcCtD
Spironolactone—Dizziness—Fluorouracil—breast cancer	2.76e-05	0.00061	CcSEcCtD
Spironolactone—Agranulocytosis—Doxorubicin—breast cancer	2.75e-05	0.000608	CcSEcCtD
Spironolactone—Rash—Mitoxantrone—breast cancer	2.75e-05	0.000607	CcSEcCtD
Spironolactone—Rash—Irinotecan—breast cancer	2.75e-05	0.000607	CcSEcCtD
Spironolactone—Dermatitis—Mitoxantrone—breast cancer	2.75e-05	0.000607	CcSEcCtD
Spironolactone—Dermatitis—Irinotecan—breast cancer	2.75e-05	0.000607	CcSEcCtD
Spironolactone—Headache—Irinotecan—breast cancer	2.73e-05	0.000603	CcSEcCtD
Spironolactone—Headache—Mitoxantrone—breast cancer	2.73e-05	0.000603	CcSEcCtD
Spironolactone—Methyltestosterone—CYP19A1—breast cancer	2.71e-05	0.0142	CrCbGaD
Spironolactone—Erythema multiforme—Epirubicin—breast cancer	2.71e-05	0.000598	CcSEcCtD
Spironolactone—Alopecia—Methotrexate—breast cancer	2.7e-05	0.000597	CcSEcCtD
Spironolactone—Vomiting—Gemcitabine—breast cancer	2.7e-05	0.000596	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—breast cancer	2.68e-05	0.000592	CcSEcCtD
Spironolactone—Rash—Gemcitabine—breast cancer	2.68e-05	0.000591	CcSEcCtD
Spironolactone—Dermatitis—Gemcitabine—breast cancer	2.68e-05	0.000591	CcSEcCtD
Spironolactone—Headache—Gemcitabine—breast cancer	2.66e-05	0.000588	CcSEcCtD
Spironolactone—Vomiting—Fluorouracil—breast cancer	2.66e-05	0.000586	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—ESR1—breast cancer	2.65e-05	0.0139	CrCbGaD
Spironolactone—Rash—Fluorouracil—breast cancer	2.63e-05	0.000582	CcSEcCtD
Spironolactone—Dermatitis—Fluorouracil—breast cancer	2.63e-05	0.000581	CcSEcCtD
Spironolactone—Hypersensitivity—Paclitaxel—breast cancer	2.62e-05	0.000579	CcSEcCtD
Spironolactone—Headache—Fluorouracil—breast cancer	2.62e-05	0.000578	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Docetaxel—breast cancer	2.6e-05	0.000575	CcSEcCtD
Spironolactone—Nausea—Mitoxantrone—breast cancer	2.59e-05	0.000572	CcSEcCtD
Spironolactone—Nausea—Irinotecan—breast cancer	2.59e-05	0.000572	CcSEcCtD
Spironolactone—Alopecia—Epirubicin—breast cancer	2.53e-05	0.000559	CcSEcCtD
Spironolactone—Nausea—Gemcitabine—breast cancer	2.52e-05	0.000557	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Capecitabine—breast cancer	2.52e-05	0.000556	CcSEcCtD
Spironolactone—Pruritus—Paclitaxel—breast cancer	2.52e-05	0.000556	CcSEcCtD
Spironolactone—Erythema multiforme—Doxorubicin—breast cancer	2.5e-05	0.000553	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—breast cancer	2.49e-05	0.000549	CcSEcCtD
Spironolactone—Nausea—Fluorouracil—breast cancer	2.48e-05	0.000548	CcSEcCtD
Spironolactone—Ill-defined disorder—Methotrexate—breast cancer	2.47e-05	0.000545	CcSEcCtD
Spironolactone—Hydrocortamate—CYP3A4—breast cancer	2.45e-05	0.0128	CrCbGaD
Spironolactone—Diarrhoea—Paclitaxel—breast cancer	2.43e-05	0.000537	CcSEcCtD
Spironolactone—Progesterone—PGR—breast cancer	2.43e-05	0.0127	CrCbGaD
Spironolactone—Cortisone acetate—CYP3A4—breast cancer	2.41e-05	0.0126	CrCbGaD
Spironolactone—Feeling abnormal—Capecitabine—breast cancer	2.41e-05	0.000531	CcSEcCtD
Spironolactone—Malaise—Methotrexate—breast cancer	2.4e-05	0.00053	CcSEcCtD
Spironolactone—Muscle spasms—Epirubicin—breast cancer	2.4e-05	0.000529	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—breast cancer	2.38e-05	0.000526	CcSEcCtD
Spironolactone—Leukopenia—Methotrexate—breast cancer	2.38e-05	0.000526	CcSEcCtD
Spironolactone—Dizziness—Paclitaxel—breast cancer	2.35e-05	0.000519	CcSEcCtD
Spironolactone—Alopecia—Doxorubicin—breast cancer	2.34e-05	0.000517	CcSEcCtD
Spironolactone—Urticaria—Capecitabine—breast cancer	2.32e-05	0.000512	CcSEcCtD
Spironolactone—Ill-defined disorder—Epirubicin—breast cancer	2.31e-05	0.00051	CcSEcCtD
Spironolactone—Body temperature increased—Capecitabine—breast cancer	2.31e-05	0.00051	CcSEcCtD
Spironolactone—Progesterone—SHBG—breast cancer	2.27e-05	0.0118	CrCbGaD
Spironolactone—Progesterone—CYP1B1—breast cancer	2.27e-05	0.0118	CrCbGaD
Spironolactone—Vomiting—Paclitaxel—breast cancer	2.26e-05	0.000499	CcSEcCtD
Spironolactone—Malaise—Epirubicin—breast cancer	2.25e-05	0.000496	CcSEcCtD
Spironolactone—Rash—Paclitaxel—breast cancer	2.24e-05	0.000495	CcSEcCtD
Spironolactone—Dermatitis—Paclitaxel—breast cancer	2.24e-05	0.000495	CcSEcCtD
Spironolactone—Discomfort—Methotrexate—breast cancer	2.24e-05	0.000495	CcSEcCtD
Spironolactone—Leukopenia—Epirubicin—breast cancer	2.23e-05	0.000492	CcSEcCtD
Spironolactone—Headache—Paclitaxel—breast cancer	2.23e-05	0.000492	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—breast cancer	2.22e-05	0.00049	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—breast cancer	2.22e-05	0.000489	CcSEcCtD
Spironolactone—Confusional state—Methotrexate—breast cancer	2.19e-05	0.000484	CcSEcCtD
Spironolactone—Anaphylactic shock—Methotrexate—breast cancer	2.17e-05	0.00048	CcSEcCtD
Spironolactone—Hypersensitivity—Capecitabine—breast cancer	2.15e-05	0.000475	CcSEcCtD
Spironolactone—Testosterone—SHBG—breast cancer	2.14e-05	0.0112	CrCbGaD
Spironolactone—Testosterone—CYP1B1—breast cancer	2.14e-05	0.0112	CrCbGaD
Spironolactone—Ill-defined disorder—Doxorubicin—breast cancer	2.14e-05	0.000472	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—breast cancer	2.13e-05	0.000471	CcSEcCtD
Spironolactone—Thrombocytopenia—Methotrexate—breast cancer	2.13e-05	0.00047	CcSEcCtD
Spironolactone—Eplerenone—CYP3A4—breast cancer	2.12e-05	0.0111	CrCbGaD
Spironolactone—Nausea—Paclitaxel—breast cancer	2.11e-05	0.000467	CcSEcCtD
Spironolactone—Discomfort—Epirubicin—breast cancer	2.1e-05	0.000463	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—breast cancer	2.08e-05	0.000459	CcSEcCtD
Spironolactone—Pruritus—Capecitabine—breast cancer	2.07e-05	0.000456	CcSEcCtD
Spironolactone—Leukopenia—Doxorubicin—breast cancer	2.06e-05	0.000456	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—breast cancer	2.06e-05	0.000455	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—breast cancer	2.05e-05	0.000453	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—breast cancer	2.03e-05	0.000449	CcSEcCtD
Spironolactone—Diarrhoea—Capecitabine—breast cancer	2e-05	0.000441	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—breast cancer	1.99e-05	0.00044	CcSEcCtD
Spironolactone—Thrombocytopenia—Epirubicin—breast cancer	1.99e-05	0.00044	CcSEcCtD
Spironolactone—Progesterone—AR—breast cancer	1.99e-05	0.0104	CrCbGaD
Spironolactone—Drospirenone—PTGS2—breast cancer	1.99e-05	0.0104	CrCbGaD
Spironolactone—Discomfort—Doxorubicin—breast cancer	1.94e-05	0.000428	CcSEcCtD
Spironolactone—Megestrol acetate—ABCB1—breast cancer	1.93e-05	0.0101	CrCbGaD
Spironolactone—Somnolence—Methotrexate—breast cancer	1.93e-05	0.000427	CcSEcCtD
Spironolactone—Dizziness—Capecitabine—breast cancer	1.93e-05	0.000426	CcSEcCtD
Spironolactone—Hydrocortisone—ABCG2—breast cancer	1.92e-05	0.01	CrCbGaD
Spironolactone—Vomiting—Docetaxel—breast cancer	1.92e-05	0.000423	CcSEcCtD
Spironolactone—Rash—Docetaxel—breast cancer	1.9e-05	0.00042	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—breast cancer	1.9e-05	0.000419	CcSEcCtD
Spironolactone—Confusional state—Doxorubicin—breast cancer	1.9e-05	0.000419	CcSEcCtD
Spironolactone—Headache—Docetaxel—breast cancer	1.89e-05	0.000417	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—breast cancer	1.88e-05	0.000415	CcSEcCtD
Spironolactone—Testosterone—AR—breast cancer	1.88e-05	0.00982	CrCbGaD
Spironolactone—Gastrointestinal disorder—Methotrexate—breast cancer	1.88e-05	0.000414	CcSEcCtD
Spironolactone—Vomiting—Capecitabine—breast cancer	1.86e-05	0.00041	CcSEcCtD
Spironolactone—Thrombocytopenia—Doxorubicin—breast cancer	1.84e-05	0.000407	CcSEcCtD
Spironolactone—Rash—Capecitabine—breast cancer	1.84e-05	0.000406	CcSEcCtD
Spironolactone—Dermatitis—Capecitabine—breast cancer	1.84e-05	0.000406	CcSEcCtD
Spironolactone—Headache—Capecitabine—breast cancer	1.83e-05	0.000404	CcSEcCtD
Spironolactone—Somnolence—Epirubicin—breast cancer	1.81e-05	0.000399	CcSEcCtD
Spironolactone—Nausea—Docetaxel—breast cancer	1.79e-05	0.000395	CcSEcCtD
Spironolactone—Feeling abnormal—Methotrexate—breast cancer	1.79e-05	0.000395	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Epirubicin—breast cancer	1.76e-05	0.000388	CcSEcCtD
Spironolactone—Nausea—Capecitabine—breast cancer	1.73e-05	0.000383	CcSEcCtD
Spironolactone—Urticaria—Methotrexate—breast cancer	1.73e-05	0.000381	CcSEcCtD
Spironolactone—Body temperature increased—Methotrexate—breast cancer	1.72e-05	0.000379	CcSEcCtD
Spironolactone—Feeling abnormal—Epirubicin—breast cancer	1.68e-05	0.00037	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—breast cancer	1.67e-05	0.000369	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.62e-05	0.000359	CcSEcCtD
Spironolactone—Urticaria—Epirubicin—breast cancer	1.62e-05	0.000357	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—breast cancer	1.61e-05	0.000355	CcSEcCtD
Spironolactone—Hypersensitivity—Methotrexate—breast cancer	1.6e-05	0.000354	CcSEcCtD
Spironolactone—Testosterone—CYP19A1—breast cancer	1.57e-05	0.00822	CrCbGaD
Spironolactone—Feeling abnormal—Doxorubicin—breast cancer	1.55e-05	0.000342	CcSEcCtD
Spironolactone—Pruritus—Methotrexate—breast cancer	1.54e-05	0.000339	CcSEcCtD
Spironolactone—Progesterone—ESR1—breast cancer	1.53e-05	0.008	CrCbGaD
Spironolactone—Hypersensitivity—Epirubicin—breast cancer	1.5e-05	0.000331	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—breast cancer	1.5e-05	0.00033	CcSEcCtD
Spironolactone—Body temperature increased—Doxorubicin—breast cancer	1.49e-05	0.000328	CcSEcCtD
Spironolactone—Diarrhoea—Methotrexate—breast cancer	1.49e-05	0.000328	CcSEcCtD
Spironolactone—Testosterone—ABCG2—breast cancer	1.48e-05	0.00772	CrCbGaD
Spironolactone—Pruritus—Epirubicin—breast cancer	1.44e-05	0.000318	CcSEcCtD
Spironolactone—Dizziness—Methotrexate—breast cancer	1.44e-05	0.000317	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—breast cancer	1.39e-05	0.000307	CcSEcCtD
Spironolactone—Hypersensitivity—Doxorubicin—breast cancer	1.39e-05	0.000306	CcSEcCtD
Spironolactone—Vomiting—Methotrexate—breast cancer	1.38e-05	0.000305	CcSEcCtD
Spironolactone—Rash—Methotrexate—breast cancer	1.37e-05	0.000303	CcSEcCtD
Spironolactone—Dermatitis—Methotrexate—breast cancer	1.37e-05	0.000302	CcSEcCtD
Spironolactone—Headache—Methotrexate—breast cancer	1.36e-05	0.000301	CcSEcCtD
Spironolactone—Medroxyprogesterone Acetate—CYP3A4—breast cancer	1.35e-05	0.00707	CrCbGaD
Spironolactone—Dizziness—Epirubicin—breast cancer	1.35e-05	0.000297	CcSEcCtD
Spironolactone—Pruritus—Doxorubicin—breast cancer	1.33e-05	0.000294	CcSEcCtD
Spironolactone—Vomiting—Epirubicin—breast cancer	1.29e-05	0.000286	CcSEcCtD
Spironolactone—Nausea—Methotrexate—breast cancer	1.29e-05	0.000285	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—breast cancer	1.29e-05	0.000284	CcSEcCtD
Spironolactone—Rash—Epirubicin—breast cancer	1.28e-05	0.000283	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—breast cancer	1.28e-05	0.000283	CcSEcCtD
Spironolactone—Methyltestosterone—CYP3A4—breast cancer	1.27e-05	0.00665	CrCbGaD
Spironolactone—Headache—Epirubicin—breast cancer	1.27e-05	0.000281	CcSEcCtD
Spironolactone—Dizziness—Doxorubicin—breast cancer	1.24e-05	0.000275	CcSEcCtD
Spironolactone—Progesterone—CYP1A1—breast cancer	1.22e-05	0.0064	CrCbGaD
Spironolactone—Nausea—Epirubicin—breast cancer	1.21e-05	0.000267	CcSEcCtD
Spironolactone—Vomiting—Doxorubicin—breast cancer	1.2e-05	0.000264	CcSEcCtD
Spironolactone—Rash—Doxorubicin—breast cancer	1.19e-05	0.000262	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—breast cancer	1.19e-05	0.000262	CcSEcCtD
Spironolactone—Headache—Doxorubicin—breast cancer	1.18e-05	0.00026	CcSEcCtD
Spironolactone—Testosterone—CYP1A1—breast cancer	1.16e-05	0.00605	CrCbGaD
Spironolactone—Nausea—Doxorubicin—breast cancer	1.12e-05	0.000247	CcSEcCtD
Spironolactone—Methyltestosterone—ALB—breast cancer	1.11e-05	0.0058	CrCbGaD
Spironolactone—Hydrocortisone—CYP3A4—breast cancer	9.6e-06	0.00501	CrCbGaD
Spironolactone—Progesterone—CYP2D6—breast cancer	9.12e-06	0.00476	CrCbGaD
Spironolactone—Hydrocortisone—ABCB1—breast cancer	7.99e-06	0.00417	CrCbGaD
Spironolactone—Progesterone—CYP3A4—breast cancer	7.82e-06	0.00408	CrCbGaD
Spironolactone—Testosterone—CYP3A4—breast cancer	7.39e-06	0.00386	CrCbGaD
Spironolactone—Progesterone—ABCB1—breast cancer	6.51e-06	0.0034	CrCbGaD
Spironolactone—Testosterone—ALB—breast cancer	6.45e-06	0.00337	CrCbGaD
Spironolactone—Testosterone—ABCB1—breast cancer	6.15e-06	0.00321	CrCbGaD
Spironolactone—PGR—Signaling Pathways—FGFR2—breast cancer	1.91e-06	4.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.91e-06	4.27e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SMAD4—breast cancer	1.91e-06	4.26e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—breast cancer	1.9e-06	4.25e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—breast cancer	1.9e-06	4.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—breast cancer	1.9e-06	4.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.89e-06	4.22e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—breast cancer	1.88e-06	4.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA2—breast cancer	1.88e-06	4.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX2—breast cancer	1.88e-06	4.21e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—breast cancer	1.88e-06	4.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX4—breast cancer	1.86e-06	4.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SULT1A1—breast cancer	1.86e-06	4.16e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—breast cancer	1.86e-06	4.16e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—breast cancer	1.86e-06	4.15e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—breast cancer	1.85e-06	4.14e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NCOR1—breast cancer	1.85e-06	4.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—breast cancer	1.85e-06	4.13e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA3—breast cancer	1.84e-06	4.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCC1—breast cancer	1.84e-06	4.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMMR—breast cancer	1.84e-06	4.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—breast cancer	1.84e-06	4.1e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TYMS—breast cancer	1.83e-06	4.09e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTA1—breast cancer	1.82e-06	4.06e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—IDH1—breast cancer	1.82e-06	4.06e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GSTM1—breast cancer	1.81e-06	4.04e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NCOR1—breast cancer	1.81e-06	4.04e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PLA2G4A—breast cancer	1.81e-06	4.04e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—H2AFX—breast cancer	1.8e-06	4.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NAT2—breast cancer	1.8e-06	4.02e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARGC1B—breast cancer	1.78e-06	3.99e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGFR1—breast cancer	1.78e-06	3.98e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NOS3—breast cancer	1.78e-06	3.97e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.77e-06	3.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—breast cancer	1.76e-06	3.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—breast cancer	1.75e-06	3.91e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—breast cancer	1.74e-06	3.89e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GPX1—breast cancer	1.73e-06	3.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—LEP—breast cancer	1.71e-06	3.83e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1A1—breast cancer	1.71e-06	3.83e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—breast cancer	1.7e-06	3.8e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—breast cancer	1.7e-06	3.8e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CAV1—breast cancer	1.7e-06	3.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—breast cancer	1.7e-06	3.79e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CA9—breast cancer	1.68e-06	3.76e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA4—breast cancer	1.68e-06	3.76e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—breast cancer	1.68e-06	3.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—breast cancer	1.66e-06	3.71e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—breast cancer	1.64e-06	3.67e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA2—breast cancer	1.64e-06	3.67e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX2—breast cancer	1.64e-06	3.67e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—breast cancer	1.64e-06	3.66e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ESR1—breast cancer	1.64e-06	3.66e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.62e-06	3.63e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—breast cancer	1.62e-06	3.63e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX4—breast cancer	1.62e-06	3.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SULT1A1—breast cancer	1.62e-06	3.62e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FN1—breast cancer	1.62e-06	3.61e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKBIA—breast cancer	1.6e-06	3.57e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—MTHFR—breast cancer	1.6e-06	3.57e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—IDH1—breast cancer	1.58e-06	3.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTA1—breast cancer	1.58e-06	3.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—breast cancer	1.58e-06	3.54e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—breast cancer	1.58e-06	3.53e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—DPYD—breast cancer	1.58e-06	3.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MED12—breast cancer	1.58e-06	3.52e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—SERPINE1—breast cancer	1.58e-06	3.52e-05	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.57e-06	3.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—breast cancer	1.57e-06	3.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NAT2—breast cancer	1.57e-06	3.5e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALDOA—breast cancer	1.55e-06	3.47e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—breast cancer	1.55e-06	3.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—breast cancer	1.55e-06	3.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—breast cancer	1.55e-06	3.46e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGF—breast cancer	1.53e-06	3.42e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA3—breast cancer	1.51e-06	3.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A2—breast cancer	1.5e-06	3.34e-05	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—breast cancer	1.49e-06	3.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.48e-06	3.31e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CAV1—breast cancer	1.47e-06	3.29e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCG2—breast cancer	1.47e-06	3.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CPT1A—breast cancer	1.47e-06	3.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTR—breast cancer	1.47e-06	3.28e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ESR1—breast cancer	1.45e-06	3.25e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—breast cancer	1.45e-06	3.25e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	1.44e-06	3.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPGDS—breast cancer	1.44e-06	3.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HBA1—breast cancer	1.43e-06	3.19e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—breast cancer	1.42e-06	3.17e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—breast cancer	1.42e-06	3.16e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT2—breast cancer	1.41e-06	3.16e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.41e-06	3.14e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—breast cancer	1.41e-06	3.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	1.4e-06	3.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTT1—breast cancer	1.39e-06	3.12e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ACHE—breast cancer	1.39e-06	3.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MED12—breast cancer	1.37e-06	3.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—DPYD—breast cancer	1.37e-06	3.07e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—breast cancer	1.36e-06	3.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALDOA—breast cancer	1.35e-06	3.02e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—breast cancer	1.35e-06	3.01e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SERPINE1—breast cancer	1.34e-06	3.01e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—breast cancer	1.34e-06	3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP17A1—breast cancer	1.32e-06	2.95e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA3—breast cancer	1.31e-06	2.93e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—breast cancer	1.31e-06	2.93e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS1—breast cancer	1.31e-06	2.92e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ENO1—breast cancer	1.31e-06	2.92e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A2—breast cancer	1.3e-06	2.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.3e-06	2.91e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.28e-06	2.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOS3—breast cancer	1.28e-06	2.87e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP2D6—breast cancer	1.28e-06	2.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ABCG2—breast cancer	1.28e-06	2.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTR—breast cancer	1.28e-06	2.85e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CPT1A—breast cancer	1.28e-06	2.85e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA2—breast cancer	1.26e-06	2.81e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPGDS—breast cancer	1.25e-06	2.8e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HBA1—breast cancer	1.24e-06	2.78e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FASN—breast cancer	1.22e-06	2.73e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—breast cancer	1.22e-06	2.72e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTT1—breast cancer	1.21e-06	2.71e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ACHE—breast cancer	1.21e-06	2.71e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BCHE—breast cancer	1.21e-06	2.71e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAF1—breast cancer	1.21e-06	2.71e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RELA—breast cancer	1.21e-06	2.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—breast cancer	1.2e-06	2.68e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—breast cancer	1.2e-06	2.68e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—SERPINE1—breast cancer	1.2e-06	2.67e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—breast cancer	1.18e-06	2.65e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MTOR—breast cancer	1.18e-06	2.65e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—breast cancer	1.18e-06	2.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	1.18e-06	2.63e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—breast cancer	1.16e-06	2.6e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—breast cancer	1.16e-06	2.59e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NQO1—breast cancer	1.16e-06	2.59e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC2A1—breast cancer	1.16e-06	2.59e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP17A1—breast cancer	1.15e-06	2.57e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—breast cancer	1.14e-06	2.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ENO1—breast cancer	1.14e-06	2.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS1—breast cancer	1.14e-06	2.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.13e-06	2.54e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP3A4—breast cancer	1.13e-06	2.52e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.12e-06	2.51e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP2D6—breast cancer	1.12e-06	2.49e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—NOS3—breast cancer	1.11e-06	2.49e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—breast cancer	1.11e-06	2.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—breast cancer	1.11e-06	2.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA2—breast cancer	1.1e-06	2.45e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—breast cancer	1.09e-06	2.44e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HSP90AA1—breast cancer	1.09e-06	2.43e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—breast cancer	1.09e-06	2.43e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	1.06e-06	2.38e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FASN—breast cancer	1.06e-06	2.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—breast cancer	1.06e-06	2.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOA1—breast cancer	1.06e-06	2.37e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—JUN—breast cancer	1.06e-06	2.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BCHE—breast cancer	1.06e-06	2.36e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—breast cancer	1.05e-06	2.35e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—breast cancer	1.04e-06	2.34e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP19A1—breast cancer	1.04e-06	2.33e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—STK11—breast cancer	1.04e-06	2.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—breast cancer	1.03e-06	2.3e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.03e-06	2.3e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—breast cancer	1.03e-06	2.29e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—breast cancer	1.03e-06	2.29e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—breast cancer	1.02e-06	2.29e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—breast cancer	1.02e-06	2.28e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NQO1—breast cancer	1.01e-06	2.26e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC2A1—breast cancer	1.01e-06	2.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK8—breast cancer	1e-06	2.24e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—breast cancer	9.99e-07	2.23e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—breast cancer	9.97e-07	2.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP3A4—breast cancer	9.84e-07	2.2e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.8e-07	2.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—COMT—breast cancer	9.71e-07	2.17e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1B1—breast cancer	9.67e-07	2.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTP1—breast cancer	9.66e-07	2.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	9.62e-07	2.15e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HMOX1—breast cancer	9.53e-07	2.13e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ITPR1—breast cancer	9.51e-07	2.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SRC—breast cancer	9.5e-07	2.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HSP90AA1—breast cancer	9.49e-07	2.12e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—breast cancer	9.47e-07	2.12e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—breast cancer	9.25e-07	2.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOA1—breast cancer	9.23e-07	2.06e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—breast cancer	9.16e-07	2.05e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—breast cancer	9.14e-07	2.04e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP19A1—breast cancer	9.1e-07	2.03e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—STK11—breast cancer	9.1e-07	2.03e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—breast cancer	9.08e-07	2.03e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TYMS—breast cancer	8.98e-07	2.01e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—breast cancer	8.88e-07	1.99e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GSTM1—breast cancer	8.88e-07	1.98e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLA2G4A—breast cancer	8.88e-07	1.98e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NCOR1—breast cancer	8.88e-07	1.98e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—breast cancer	8.75e-07	1.96e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—breast cancer	8.51e-07	1.9e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPX1—breast cancer	8.5e-07	1.9e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TGFB1—breast cancer	8.49e-07	1.9e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—COMT—breast cancer	8.46e-07	1.89e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTP1—breast cancer	8.42e-07	1.88e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1A1—breast cancer	8.42e-07	1.88e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—breast cancer	8.35e-07	1.87e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—breast cancer	8.32e-07	1.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HMOX1—breast cancer	8.3e-07	1.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ITPR1—breast cancer	8.28e-07	1.85e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—breast cancer	8.16e-07	1.82e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—breast cancer	7.86e-07	1.76e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTHFR—breast cancer	7.85e-07	1.75e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TYMS—breast cancer	7.82e-07	1.75e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—breast cancer	7.78e-07	1.74e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NCOR1—breast cancer	7.73e-07	1.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GSTM1—breast cancer	7.73e-07	1.73e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLA2G4A—breast cancer	7.73e-07	1.73e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—breast cancer	7.56e-07	1.69e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GPX1—breast cancer	7.41e-07	1.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP1A1—breast cancer	7.33e-07	1.64e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—breast cancer	7.27e-07	1.63e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CAV1—breast cancer	7.24e-07	1.62e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—breast cancer	7.22e-07	1.61e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—breast cancer	6.99e-07	1.56e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—breast cancer	6.91e-07	1.55e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.91e-07	1.55e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTHFR—breast cancer	6.84e-07	1.53e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—breast cancer	6.68e-07	1.49e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—breast cancer	6.59e-07	1.47e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—breast cancer	6.4e-07	1.43e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CAV1—breast cancer	6.3e-07	1.41e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—breast cancer	6.27e-07	1.4e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—breast cancer	5.9e-07	1.32e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—breast cancer	5.79e-07	1.3e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—breast cancer	5.74e-07	1.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—breast cancer	5.72e-07	1.28e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NOS3—breast cancer	5.47e-07	1.22e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—breast cancer	5.25e-07	1.17e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—breast cancer	5.12e-07	1.14e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—breast cancer	5.05e-07	1.13e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—breast cancer	5.05e-07	1.13e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—breast cancer	5e-07	1.12e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—breast cancer	4.98e-07	1.11e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NOS3—breast cancer	4.77e-07	1.07e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—breast cancer	4.4e-07	9.84e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—breast cancer	4.36e-07	9.76e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—breast cancer	4.36e-07	9.75e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—breast cancer	3.8e-07	8.5e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—breast cancer	3.08e-07	6.88e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—breast cancer	2.68e-07	6e-06	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—breast cancer	2.52e-07	5.62e-06	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—breast cancer	2.19e-07	4.9e-06	CbGpPWpGaD
